Inventiva (IVA) Loans - Gross (2019 - 2025)
Inventiva (IVA) posted quarterly Loans - Gross of $150.3 million for Q2 2025, up 90.17% year-over-year from $79.0 million in Q2 2024, and down 34.4% quarter-over-quarter from $229.2 million in Q4 2024.
Inventiva (IVA) Loans - Gross (2019 - 2025) Analysis & Trends
Inventiva's Loans - Gross history runs 7 years deep, the most recent figure standing at $150.3 million for Q2 2025.
- In Q2 2025, Loans - Gross rose 90.17% year-over-year to $150.3 million; the TTM figure through Jun 2025 stood at $150.3 million (up 90.17% YoY), while the FY2024 annual figure was $229.2 million, up 1469.61% from the prior year.
- Loans - Gross for Q2 2025 stood at $150.3 million, down from $229.2 million in the prior quarter.
- The five-year high for Loans - Gross was $229.2 million in Q4 2024, with the low at $14.6 million in Q4 2023.
- The 5-year median for Loans - Gross is $93.5 million (2022), against an average of $98.0 million.
- The sharpest annual moves came in 2023 and 2024: Loans - Gross sank 84.1% in 2023, then surged 1469.61% in 2024.
- Inventiva's Loans - Gross stood at $26.1 million in 2021, then surged by 251.36% to $91.8 million in 2022, then tumbled by 84.1% to $14.6 million in 2023, then soared by 1469.61% to $229.2 million in 2024, then tumbled by 34.4% to $150.3 million in 2025.
- Business Quant data shows IVA's Loans - Gross at $150.3 million in Q2 2025, $229.2 million in Q4 2024, and $79.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Gross (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 150.32 Mn |
| Dec 31, 2024 | 229.15 Mn |
| Jun 30, 2024 | 79.05 Mn |
| Dec 31, 2023 | 14.60 Mn |
| Jun 30, 2023 | 98.02 Mn |
| Dec 31, 2022 | 91.84 Mn |
| Jun 30, 2022 | 95.15 Mn |
| Jun 30, 2021 | 26.14 Mn |
| Jun 30, 2020 | 63.56 Mn |
| Dec 31, 2019 | 43.77 Mn |